Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CCR4 as a novel molecular target for immunotherapy of cancer
Takashi Ishida, Ryuzo Ueda
Cancer Science (2006) Vol. 97, Iss. 11, pp. 1139-1146
Open Access | Times Cited: 236

Showing 1-25 of 236 citing articles:

A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
Sijin Cheng, Ziyi Li, Ranran Gao, et al.
Cell (2021) Vol. 184, Iss. 3, pp. 792-809.e23
Open Access | Times Cited: 934
Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
Takashi Ishida, Tatsuro Joh, Naokuni Uike, et al.
Journal of Clinical Oncology (2012) Vol. 30, Iss. 8, pp. 837-842
Open Access | Times Cited: 618
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
Daisuke Sugiyama, Hiroyoshi Nishikawa, Yuka Maeda, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 44, pp. 17945-17950
Open Access | Times Cited: 583
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
James B. Wing, Atsushi Tanaka, Shimon Sakaguchi
Immunity (2019) Vol. 50, Iss. 2, pp. 302-316
Open Access | Times Cited: 583
CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile
Elena Sierra‐Filardi, Concha Nieto, Ángeles Domínguez‐Soto, et al.
The Journal of Immunology (2014) Vol. 192, Iss. 8, pp. 3858-3867
Open Access | Times Cited: 429
The chemokine system in cancer biology and therapy
Alberto Mantovani, Benedetta Savino, Massimo Locati, et al.
Cytokine & Growth Factor Reviews (2009) Vol. 21, Iss. 1, pp. 27-39
Closed Access | Times Cited: 376
CCR4 and its ligands: from bench to bedside
Osamu Yoshie, Kouji Matsushima
International Immunology (2014) Vol. 27, Iss. 1, pp. 11-20
Open Access | Times Cited: 360
Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma
Kazuhito Yamamoto, Atae Utsunomiya, Kensei Tobinai, et al.
Journal of Clinical Oncology (2010) Vol. 28, Iss. 9, pp. 1591-1598
Open Access | Times Cited: 348
Chemokine-Induced Macrophage Polarization in Inflammatory Conditions
Pieter Ruytinx, Paul Proost, Jo Van Damme, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 346
Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Michinori Ogura, Takashi Ishida, Kiyohiko Hatake, et al.
Journal of Clinical Oncology (2014) Vol. 32, Iss. 11, pp. 1157-1163
Open Access | Times Cited: 337
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
Yoshiki Mizukami, Koji Kono, Yoshihiko Kawaguchi, et al.
International Journal of Cancer (2008) Vol. 122, Iss. 10, pp. 2286-2293
Closed Access | Times Cited: 335
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
Sergio A. Quezada, Karl S. Peggs, Tyler R. Simpson, et al.
Immunological Reviews (2011) Vol. 241, Iss. 1, pp. 104-118
Open Access | Times Cited: 263
CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes
Moritz Rapp, Maximilian W. M. Wintergerst, Wolfgang G. Kunz, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 5, pp. 1170-1181
Open Access | Times Cited: 188
Principles of regulatory T cell function
Stanislav Dikiy, Alexander Y. Rudensky
Immunity (2023) Vol. 56, Iss. 2, pp. 240-255
Open Access | Times Cited: 158
High-throughput single-сell sequencing in cancer research
Qingzhu Jia, Han Chu, Jin Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 91
Immunotherapy of Cancer by Targeting Regulatory T cells
Bo-Jin Chen, Jingwen Zhao, Dahong Zhang, et al.
International Immunopharmacology (2022) Vol. 104, pp. 108469-108469
Open Access | Times Cited: 76
In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue
Zhi Li, Zewen Kelvin Tuong, Isaac Dean, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 76
Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma
Toshihiko Ishii, Takashi Ishida, Atae Utsunomiya, et al.
Clinical Cancer Research (2010) Vol. 16, Iss. 5, pp. 1520-1531
Closed Access | Times Cited: 231
Prognostic significance and mechanism of Treg infiltration in human brain tumors
Joannes F.M. Jacobs, Albert J. S. Idema, Kalijn F. Bol, et al.
Journal of Neuroimmunology (2010) Vol. 225, Iss. 1-2, pp. 195-199
Open Access | Times Cited: 202
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.
Darryl A. Oble, Robert Loewe, Ping Yu, et al.
PubMed (2009) Vol. 9, pp. 3-3
Closed Access | Times Cited: 186
Engineered therapeutic antibodies with improved effector functions
Tsuguo Kubota, Rinpei Niwa, Mitsuo Satoh, et al.
Cancer Science (2009) Vol. 100, Iss. 9, pp. 1566-1572
Open Access | Times Cited: 148
Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization
Elisabetta Marcuzzi, Roberta Angioni, Barbara Molon, et al.
International Journal of Molecular Sciences (2018) Vol. 20, Iss. 1, pp. 96-96
Open Access | Times Cited: 142
Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma)
Claire Dearden, Rod Johnson, Ruth Pettengell, et al.
British Journal of Haematology (2011) Vol. 153, Iss. 4, pp. 451-485
Open Access | Times Cited: 114
Regulatory T Cells in Tumor Microenvironment and Approach for Anticancer Immunotherapy
Jung-Ho Kim, Beom Seok Kim, Sang‐Kyou Lee
Immune Network (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 112
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1
Caroline Imbert, Anne Montfort, Marine Fraisse, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 110
Page 1 - Next Page

Scroll to top